Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 243

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 9
Chunk 243
---
Item 9. The Offer and Listing.

A. Offer and Listing Details.

The Company's ADSs have been listed on the Nasdaq Global Select Market under the symbol “ IPHA” since October 21, 2019. The Company's ordinary shares have been trading on Euronext Paris under the symbol “ IPH” since November 3, 2006. Prior to that date, there was no public trading market for the Company's ADSs or its ordinary shares.

B. Plan of Distribution.

Not applicable.

C. Markets.

The Company's ADSs have been listed on Nasdaq under the symbol “ IPHA” since October 21, 2019. The Company's ordinary shares have been trading on Euronext Paris under the symbol “ IPH” since November 3, 2006.

D. Selling Shareholders.

Not applicable.

E. Dilution.

Not applicable.

F. Expenses of the Issue.

Not applicable.

Item 10. Additional Information.